Jorge A. Quiroz

10.2k total citations
43 papers, 3.7k citations indexed

About

Jorge A. Quiroz is a scholar working on Psychiatry and Mental health, Cellular and Molecular Neuroscience and Biological Psychiatry. According to data from OpenAlex, Jorge A. Quiroz has authored 43 papers receiving a total of 3.7k indexed citations (citations by other indexed papers that have themselves been cited), including 23 papers in Psychiatry and Mental health, 17 papers in Cellular and Molecular Neuroscience and 9 papers in Biological Psychiatry. Recurrent topics in Jorge A. Quiroz's work include Bipolar Disorder and Treatment (19 papers), Neuroscience and Neuropharmacology Research (13 papers) and Tryptophan and brain disorders (9 papers). Jorge A. Quiroz is often cited by papers focused on Bipolar Disorder and Treatment (19 papers), Neuroscience and Neuropharmacology Research (13 papers) and Tryptophan and brain disorders (9 papers). Jorge A. Quiroz collaborates with scholars based in United States, Belgium and Czechia. Jorge A. Quiroz's co-authors include Carlos A. Zarate, Husseini K. Manji, Dennis S. Charney, Jaskaran Singh, David A. Luckenbaugh, Jennifer L. Payne, Kirk D. Denicoff, N. A. B. Gray, Husseini K. Manji and Jonathan Sporn and has published in prestigious journals such as SHILAP Revista de lepidopterología, American Journal of Psychiatry and Biological Psychiatry.

In The Last Decade

Jorge A. Quiroz

38 papers receiving 3.5k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Jorge A. Quiroz United States	26	1.8k	1.2k	1.0k	939	612	43	3.7k
Joanna Hauser Poland	36	1.6k 0.9×	907 0.8×	1.1k 1.1×	658 0.7×	753 1.2×	158	4.5k
Tetsuro Ohmori Japan	37	1.3k 0.8×	1.3k 1.1×	774 0.8×	376 0.4×	1.2k 1.9×	180	4.4k
Chen‐Jee Hong Taiwan	39	1.0k 0.6×	1.9k 1.6×	613 0.6×	449 0.5×	907 1.5×	114	4.2k
Toshiya Inada Japan	37	1.5k 0.9×	2.0k 1.7×	556 0.6×	774 0.8×	1.8k 2.9×	273	5.6k
Peixiong Yuan United States	38	1.1k 0.6×	2.0k 1.7×	2.0k 2.0×	1.6k 1.7×	1.7k 2.7×	62	5.6k
Husseini K. Manji United States	38	2.6k 1.5×	1.8k 1.6×	854 0.8×	406 0.4×	1.9k 3.1×	61	5.6k
L. Trevor Young Canada	26	1.9k 1.1×	623 0.5×	536 0.5×	263 0.3×	739 1.2×	41	3.2k
Leda Leme Talib Brazil	32	1.1k 0.6×	625 0.5×	538 0.5×	316 0.3×	640 1.0×	122	3.4k
Elizabeth Scarr Australia	39	962 0.5×	2.4k 2.0×	869 0.9×	666 0.7×	2.4k 3.9×	127	4.7k
Ying‐Jay Liou Taiwan	30	881 0.5×	690 0.6×	404 0.4×	274 0.3×	593 1.0×	122	2.6k

Countries citing papers authored by Jorge A. Quiroz

Since Specialization

Citations

This map shows the geographic impact of Jorge A. Quiroz's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jorge A. Quiroz with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jorge A. Quiroz more than expected).

Fields of papers citing papers by Jorge A. Quiroz

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jorge A. Quiroz. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jorge A. Quiroz. The network helps show where Jorge A. Quiroz may publish in the future.

Co-authorship network of co-authors of Jorge A. Quiroz

This figure shows the co-authorship network connecting the top 25 collaborators of Jorge A. Quiroz. A scholar is included among the top collaborators of Jorge A. Quiroz based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jorge A. Quiroz. Jorge A. Quiroz is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Kelly, Kristina, Amy Bartlett, John B. Hutchison, et al.. (2024). Neuromuscular transmission deficits in patients with CMT and ClC‐1 inhibition in CMT animal models. Annals of Clinical and Translational Neurology. 12(2). 320–331.

Gidaro, Teresa, et al.. (2024). 103P NMD670, a first-in-class skeletal muscle ClC-1 Inhibitor in Charcot-Marie-Tooth disease: the SYNAPSE-CMT phase 2 study. Neuromuscular Disorders. 43. 104441.573–104441.573.

Quiroz, Jorge A., et al.. (2023). La juventud y la ley en Colombia: la ciudadanía juvenil en el contexto de la democracia digital. SHILAP Revista de lepidopterología. 11–34.

Youssef, Eriene, Elizabeth Berry‐Kravis, Christian Czech, et al.. (2017). Effect of the mGluR5-NAM Basimglurant on Behavior in Adolescents and Adults with Fragile X Syndrome in a Randomized, Double-Blind, Placebo-Controlled Trial: FragXis Phase 2 Results. Neuropsychopharmacology. 43(3). 503–512. 93 indexed citations

Quiroz, Jorge A., Dennis Deptula, Ludger Banken, et al.. (2016). Efficacy and Safety of Basimglurant as Adjunctive Therapy for Major Depression. JAMA Psychiatry. 73(7). 675–675. 103 indexed citations

Yang, Jui‐Chen, et al.. (2015). Caregiver Preferences for the Treatment of Males with Fragile X Syndrome. Journal of Developmental & Behavioral Pediatrics. 37(1). 71–79. 15 indexed citations

Nasrallah, Henry A., Srihari Gopal, Cristiana Gassmann-Mayer, et al.. (2010). A Controlled, Evidence-Based Trial of Paliperidone Palmitate, A Long-Acting Injectable Antipsychotic, in Schizophrenia. Neuropsychopharmacology. 35(10). 2072–2082. 126 indexed citations

Haas, Magali, Alan S. Unis, Jorge L. Armenteros, et al.. (2009). A 6-Week, Randomized, Double-Blind, Placebo-Controlled Study of the Efficacy and Safety of Risperidone in Adolescents with Schizophrenia. Journal of Child and Adolescent Psychopharmacology. 19(6). 611–621. 100 indexed citations

Moore, Gregory J., Bernadette M. Cortese, Debra Glitz, et al.. (2009). A Longitudinal Study of the Effects of Lithium Treatment on Prefrontal and Subgenual Prefrontal Gray Matter Volume in Treatment-Responsive Bipolar Disorder Patients. The Journal of Clinical Psychiatry. 70(5). 699–705. 143 indexed citations

10.

Haas, Magali, Melissa P. DelBello, Gahan Pandina, et al.. (2009). Risperidone for the treatment of acute mania in children and adolescents with bipolar disorder: a randomized, double‐blind, placebo‐controlled study. Bipolar Disorders. 11(7). 687–700. 120 indexed citations

11.

Quiroz, Jorge A., N. A. B. Gray, Tadafumi Kato, & Husseini K. Manji. (2008). Mitochondrially Mediated Plasticity in the Pathophysiology and Treatment of Bipolar Disorder. Neuropsychopharmacology. 33(11). 2551–2565. 133 indexed citations

12.

Quiroz, Jorge A., et al.. (2007). Preparation of a respiratory syncytial virus human reference serum for use in the quantitation of neutralization antibody. Biologicals. 35(3). 183–187. 10 indexed citations

13.

Zarate, Carlos A., Jaskaran Singh, Jorge A. Quiroz, et al.. (2006). A Double-Blind, Placebo-Controlled Study of Memantine in the Treatment of Major Depression. American Journal of Psychiatry. 163(1). 153–155. 310 indexed citations

14.

Quiroz, Jorge A., et al.. (2005). Development of an improved microneutralization assay for respiratory syncytial virus by automated plaque counting using imaging analysis. Virology Journal. 2(1). 84–84. 51 indexed citations

15.

Zarate, Carlos A., Jorge A. Quiroz, Jaskaran Singh, et al.. (2005). An open-label trial of the glutamate-modulating agent riluzole in combination with lithium for the treatment of bipolar depression. Biological Psychiatry. 57(4). 430–432. 192 indexed citations

16.

Du, Jing, Jorge A. Quiroz, Peixiong Yuan, Carlos A. Zarate, & Husseini K. Manji. (2004). Bipolar disorder: involvement of signaling cascades and AMPA receptor trafficking at synapses. PubMed. 1(3). 231–243. 33 indexed citations

17.

Du, Jing, et al.. (2004). Regulation of cellular plasticity and resilience by mood stabilizers: the role of AMPA receptor trafficking. Dialogues in Clinical Neuroscience. 6(2). 143–155. 9 indexed citations

18.

Zarate, Carlos A., Jennifer L. Payne, Jaskaran Singh, et al.. (2004). Pramipexole for bipolar II depression: a placebo-controlled proof of concept study. Biological Psychiatry. 56(1). 54–60. 246 indexed citations

19.

Quiroz, Jorge A., Jaskaran Singh, Todd D. Gould, et al.. (2004). Emerging experimental therapeutics for bipolar disorder: clues from the molecular pathophysiology. Molecular Psychiatry. 9(8). 756–776. 50 indexed citations

20.

Rohwer, Forest, et al.. (1999). IL-2-mediated cell cycle progression and inhibition of apoptosis does not require NF-kappa B or activating protein-1 activation in primary human T cells.. PubMed. 162(6). 3308–15. 18 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact